M. Lohmann-Matthes et al., "Pulmonary Macrophages," Eur. Respir. J. 7:1678-1689 (1994). |
J. Langermans et al., "Antimicrobial Functions of Mononuclear Phagocytes," J. Immunol. Methods 174:185-194 (1994). |
S. Nelson et al., "Pathology of Pneunomia," Clin. Chest Med. 16(1):1-12 (1995). |
E. Goetzl et al., "Specificity of Expression and Effects of Eicosanoid Mediators in Normal Physiology and Human Diseases," FASEB J 9:1051-1058 (1995). |
J. Woods et al., "5-Lipoxygenase Is Located In the Euchromatin of the Nucleaus in Resting Human Alveolar Macrophages and Translocates to the Nuclear Envelope Upon Cell Activation," J. Clin. Invest. 95:2035-2040 (1995). |
M. Peters-Golden et al., "Alterations In the Pattern of Arachidonate Metabolism Accompany Rat Macrophage Differentiation In the Lung," J. Immunol. 144(1):263-270 (1990). |
T. Martin et al., Relative Contribution of Leukotriene B.sub.4 to the Neutrophil Chemotactic Activity Produced by the Resident Human Alveolar Macrophage, J. Clin. Invest. 80:1114-1124 (1989). |
T. Martin et al., Effects of leukotriene B.sub.4 in the Human Lung. Recruitment of Neutrophils Into the Alveolar Spaces Without a Change in Protein Permeability, J. Clin. Invest. 84(5):1609-1619. |
T. Demitsu et al., "Phagocytosis and Bactericidal Action of Mouse Peritoneal Macrophages Treated With Leukotriene B.sub.4," Int. J. Immunopharmac. 11(7):801-808 (1989). |
P. Marder et al., "Blockade of Human Neutrophil Activation by 2-�2-Propyl-3�3-�2�Ethyl-4-(4-Fluorophenly)-5-Hydroxyphenoxy!Propoxy!Phenoxy!Benzioc Acid (LY293111), A Novel Leukotriene B.sub.4 Receptor Antagonist," Biochem. Pharmacol. 49(11):1683-1690 (1995). |
C. Serhan et al., "Leukotriene B.sub.4 Is A Complete Secretagogue In Human Neutrophils: A Kinetic Analysis," Biochem. Biophys. Res. Commun. 107(3):1006-1012 (1982). |
J. Wijkander et al., "5-Lipoxygenase Products Modulate the Activity of the 85-kDa Phospholipase A.sub.2 in Human Neutrophils," J. Biol. Chem. 270(44):26543-26549 (1995). |
J. O'Flaherty et al., "Mechanisms Involved In the Bidirectional Effects of Protien Kinase C Activators on Neutrophil Responses to Leukotriene B.sub.4," J. Immunol. 144(5):1909-1913 (1990). |
R. Strieter et al., "Cycotine-induced Neutrophil-derived Interlukin-8," Am. J. Pathol. 141(2):397-407 (1992). |
R. Bray and Z. Brahmi, "Role of Lipoxygenation in Human Natural Killer Cell Activation," J. Immunol. 136(5):1783-1790 (1986). |
J. Rhodes et al., "Macrophage Fc.gamma..sub.2b Receptor Expression and Receptor-Mediated Phospholipase Activity: Regulation By Endogenous Eicosanoids," Eur. J. Immunol. 15:222-227 (1985). |
M. Peppelenbosch et al., "Epidermal Growth Factor-Induced Actin Remodeling Is Regulated by 5-Lipoxygenase and Cyclooxygenase Products," Cell 74:565-575 (1993). |
A. Buret et al., Effector Mechanisms of Intestinally Induced Immunity To Pseudomonas Aeruginosa in the Rat Lung: Role of Neutrophils and Leukotriene B.sub.4, Infect. Immun. 61(2):671-679 (1993). |
H. Hopkins et al., "Neutrophil Chemotactic Factors in Bacterial Pneumonia," Chest 95(5):1021-1027 (1989). |
R. Moqbel et al., "Enhancement of Neutrophil- and Eosinophil-mediated Complement-dependent Killing of Schistosomula of Schistosoma Mansoni In Vitro By Leukotriene B.sub.4," Clin. Exp. Immunol. 52:519-527 (1983). |
M. Balter et al., "Different Patterns of Arachidonate Metablism In Autologous Human Blood Monocytes and Alveolar Macrophages," J. Immunol. 142(2):602-608 (1989). |
T.G. Brock et al., "Localization of 5-Lipoxygenase to the Nucleus of Unstimulated Rat Basophilic Leukemia Cells," J. Biol. Chem. 269(46):22059-22066 (1994). |
M. Balter et al., "Multiple defects In Arachidonate Metabolism In Alveolar Macrophages From Young Asymptomatic Smokers," J. Lab.Clin. Med. 114:662-673 (1989). |
M. Coffey et al., "5-Lipoxygenase Metabolism In Alveolar From Subjects Infected With thte Human Immunodeficiency Virus," J. Immunol. 157:393-399 (1996). |
M.J. Coffey et al., "Reduced 5-Lipoxygenase Metabolism of Arachidonic Acid in Macrophages Rrom 1, 25-Dihydroxyvitamin D.sub.3 -Deficient Rats," Prostaglandins. 48:313-329 (1994). |
J. Goulet et al., "Altered Inflammatory Responses In Leukotriene-Deficient Mice," Proc. Natl. Acad. Sci. USA 91:12852-12856 (1994). |
X. Chen et al., "Role of Leukotrienes Revealed By Targeted Disruption of the 5-Lipoxygenase Gene," Nature 372:179-182 (1994). |
McColm et al., "Evaluation of Ceftazidime In Experimental Klebsiela Pneumoniae Pneumonia: Comparison With Other Antibiotics qand Measurements of Its Penetration Into Respiratory Tissues and Secretions," J. Antimicrob. Chemother. 18:599-608 (1986). |
M. Greenberger et al., "Neutralization of IL-10 Increases Survival In a Murine Model of Klebsiella Pneumonia," J. Immunol. 155:722-729 (1995). |
M. Schneemann et al., "Nitric Oxide Synthase Is Not a Constituent of the Antimicrobial Armature of Human Mononuclear Phagocytes," J. Infect. Dis. 167:1358-1363 (1993). |
J. Wilborn et al., "Constitutive Activation of 5-Lipoxygenase in the Lungs of Patients with Idiopathic Pulmonary Fibrosis," J. Clin. Invest. 97(8):1827-1836 (1996). |
L. Laichalk et al., "Interleukin-10 Inhibits Neutrophil Phagocytic and Bactericidal Activity,"FEMS Immunol. Med. Microbiol. 658:1-7 (1996). |
R. Crowell et al., "Hyperoxic Suppression of Fc-.gamma. Receptor-mediated Phagocytosis By Isolated Murine Pulmonary Macrophages," Am. J. Respir. Cell Mol. Biol. 12:190-195 (1995). |
W. Hsueh et al., "LTB.sub.4 Production and Lysosomal Enzyme Release by Rat Alveolar Macrophages: Effects of Phagocytosis, Receptor Binding, and Ionophore Stimulation," Exp. Lung Res. 13:385-399 (1987). |
G. Rosen et al., "Free Radicals and Phagocytic Cells,"FASEB J. 9:200-209 (1995). |
N. Hubbard and K. Erickson, Role of 5'-Lipoxygenase Metabolites in the Activation of Peritoneal Macrophages for Tumoricidal Function, Mol. Immunol. 160:115-122 (1995). |
N. Ahmed et al., "Transgenic Mice Expressing Rabbit C-Reactive Protein Exhibit Diminished Chemotatic Factor-Induced Alveolitis," Am. J. Respir. Crit. Care Med. 153:1141-1147 (1996). |
W. Smith et al., "Characterization of 5-Lipoxygenase Inhibitors In Biochemical and Functional In Vivo Assays," J. Pharmacol. Exp. Ther. 275:1322-1338 (1995). |
J. Drazen et al., Comparative Airway and Vascular Activities of Leukotrienes C-1 and In Vivo and In Vitro, Proc. Natl. Acad. Sci USA 77:4354-4358 (1980). |
R. Harris et al., "Clinical Activity of Leukotriene Inhibitors," Int. J. Immunopharmac. 17(2):147-156 (1995. |
R. Malaviya et al., "Reversible Translocation of 5-Lipoxygenase in Mast Cells Upon IgE," JBC 268(7):4939-4944 (1993). |
I. Pavord et al., "Effect of Inhaled Prostaglandin E.sub.2 on Allergen-Induced Asthma," Am Rev Respir. Dis148:87-90 (1993). |
M. Baile et al., "Leukotriene-Deficient Mice Manifest Enhanced Lethality from Klebsiella Pneumonia in Association with Decreased Alveolar Macrophage Phagocytic and Bactericidal Activities," The Journal of Immunology 157:5221-5224 (1996). |